Virbac SA
SWB:V16
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virbac SA
SWB:V16
|
FR |
|
C
|
Cafe24 Corp
KOSDAQ:042000
|
KR |
Intrinsic Value
The intrinsic value of 
Virbac SA (V16) under the Base Case is 344.84 EUR per share.
Compared with the current market price of 311.5 EUR, the stock appears
Undervalued by 10% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Virbac Does
Virbac SA is an animal health company. It makes and sells medicines, vaccines, diagnostic products, and other care products for pets and farm animals. Its lineup includes treatments for parasites, skin and ear conditions, vaccines, and veterinary nutrition products.
- Headquarters
- France FR
- Employees
- 6 442
- IPO date
- Jan 1, 1985
Virbac has no economic moat
Virbac SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Virbac SA
The intrinsic value for Virbac SA (V16) under the Base Case is 344.84 EUR.
Compared with the current market price of 311.5 EUR, the stock appears Undervalued by 10% .